FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-29
DOI
10.1186/s13046-019-1236-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
- (2018) Junqiang Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- Fibroblast growth factor receptors as treatment targets in clinical oncology
- (2018) Masaru Katoh Nature Reviews Clinical Oncology
- Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study
- (2017) Lucia Nogova et al. JOURNAL OF CLINICAL ONCOLOGY
- Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs
- (2017) Todd P. Knutson et al. Journal of Hematology & Oncology
- Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification
- (2017) Fiona Tsui-Fen Cheng et al. Journal of the National Comprehensive Cancer Network
- Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility
- (2017) Yafei Zhang et al. MEDICINE
- FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
- (2017) Lukasz Turczyk et al. NEOPLASIA
- Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
- (2016) Maya Ghoussaini et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis
- (2016) Fei Cui et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness
- (2016) Thomas M. Campbell et al. CARCINOGENESIS
- Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
- (2016) Heather M. Brechbuhl et al. CLINICAL CANCER RESEARCH
- Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.
- (2016) Elizabeth Catherine Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients
- (2016) David G. Cox et al. Oncotarget
- The role of tumor microenvironment in therapeutic resistance
- (2016) Beomseok Son et al. Oncotarget
- Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
- (2016) Dominika Piasecka et al. Oncotarget
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
- (2015) T. Helsten et al. CLINICAL CANCER RESEARCH
- Progesterone receptor modulates ERα action in breast cancer
- (2015) Hisham Mohammed et al. NATURE
- Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
- (2015) Isaac Garcia-Murillas et al. Science Translational Medicine
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Abstract 5446: FPA144: A therapeutic antibody for treating patients with gastric cancers bearing FGFR2 gene amplification
- (2015) Abigael T. Gemo et al. CANCER RESEARCH
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
- (2014) Shicheng Su et al. CANCER CELL
- Fgf10: A Paracrine-Signaling Molecule in Development, Disease, and Regenerative Medicine
- (2014) N. Itoh et al. CURRENT MOLECULAR MEDICINE
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
- (2013) Kai Hung Tiong et al. APOPTOSIS
- A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition
- (2013) Hans-Peter Sinn et al. Breast Care
- Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
- (2013) F. Andre et al. CLINICAL CANCER RESEARCH
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss
- (2013) Lisa Braun et al. MODERN PATHOLOGY
- Blockade of Nonhormonal Fibroblast Growth Factors by FP-1039 Inhibits Growth of Multiple Types of Cancer
- (2013) T. C. Harding et al. Science Translational Medicine
- Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk
- (2012) Hong Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis
- (2012) Liping Zhou et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer
- (2012) A. N. Brooks et al. CLINICAL CANCER RESEARCH
- 621 A Phase I Dose-escalation Study of MFGR1877S, a Human Monoclonal Anti-fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients (pts) with Advanced Solid Tumors
- (2012) P. ODonnell et al. EUROPEAN JOURNAL OF CANCER
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer
- (2012) Susann Busch et al. PLoS One
- Fibroblast Growth Factor Receptor Signaling Is Essential for Normal Mammary Gland Development and Stem Cell Function
- (2012) Adam C. Pond et al. STEM CELLS
- Fibroblast growth factors and their receptors in cancer
- (2011) Jørgen Wesche et al. BIOCHEMICAL JOURNAL
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Interaction between FGFR-2, STAT5, and Progesterone Receptors in Breast Cancer
- (2011) J. P. Cerliani et al. CANCER RESEARCH
- Mechanisms of FGFR3 actions in endocrine resistant breast cancer
- (2011) D.C. Tomlinson et al. INTERNATIONAL JOURNAL OF CANCER
- Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth
- (2010) Victoria T Fabris et al. BMC CANCER
- Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer
- (2010) Chenyou Jia et al. BREAST CANCER RESEARCH AND TREATMENT
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
- (2010) N. Turner et al. CANCER RESEARCH
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- FGFR2 intronic SNPs and breast cancer risk: Associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors
- (2010) Catalin Marian et al. INTERNATIONAL JOURNAL OF CANCER
- Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling
- (2010) C. M. Fillmore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hormone Action in the Mammary Gland
- (2010) C. Brisken et al. Cold Spring Harbor Perspectives in Biology
- The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
- (2009) Claudia Lanari et al. ENDOCRINE-RELATED CANCER
- Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia
- (2009) Uljana A Boyarskikh et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation
- (2009) Hany Abdel-Hafiz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Estrogen Receptor Alpha Represses Transcription of Early Target Genes via p300 and CtBP1
- (2009) F. Stossi et al. MOLECULAR AND CELLULAR BIOLOGY
- Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women
- (2008) J. Liang et al. CARCINOGENESIS
- Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase
- (2008) J. Matsui et al. CLINICAL CANCER RESEARCH
- Microenvironmental regulation of cancer development
- (2008) Min Hu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling
- (2008) Sara Parsa et al. DEVELOPMENTAL BIOLOGY
- Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer
- (2008) D. Meijer et al. ENDOCRINE-RELATED CANCER
- Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
- (2008) Sebastián Giulianelli et al. INTERNATIONAL JOURNAL OF CANCER
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
- Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics
- (2008) Montserrat Garcia-Closas et al. PLoS Genetics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now